Checked.be
Active
BE 0690.585.065Private limited company
MARIE VLS
Rue Sainte-Aldegonde(K) 52 ·7540 Tournai, Belgium· 8 yrs active
Sector: Physiotherapy
(86951)
Conclusion
MARIE VLS has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39k and a net result of €23k. Equity is growing by ~10.4% per year across the filed fiscal years. Its solvency ranks better than 41% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 6 annual accounts.
Key figures
| Equity | €39k |
| Net result | €23k |
| Better than sector | 41% |
| Active | 8 yrs |
Financial profile
93
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
98
Profitability
100
Solvency
90
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2018, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
98
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€4k
estimate, not credit advice
Score history
85
2020
93
2021
100
2022
70
2023
100
2024
98
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.73 (≥ 1.5)
+10
Quick ratio
Quick ratio 1.73 (≥ 1.0)
+5
Leverage
Debt/equity 0.91 (< 1.0)
+10
Profitability
ROE 59% (≥ 10%)
+10
Interest coverage
Interest coverage 73.6× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 28-07-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~10.4%/year over 6 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 52.4% | 63.4% | |
| Net result | €23k | €62k | |
| Equity | €39k | €132k | |
| Gross operating margin | €42k | €116k | |
| Total assets | €74k | €286k |
€41k
+254.4%
20-25
€23k
+283.4%
20-25
€30k
+136.4%
20-25
€74k
+34.2%
20-25
€39k
-2.5%
20-25
€26k
-2.8%
20-25
€13k
+423.0%
20-25
€24k
-
20-25
€35k
+129.2%
20-25
€35k
+249.8%
20-25
€5k
-51.3%
20-25
1.73
-52.2%
20-25
1.73
-52.2%
20-25
52.4%
-27.3%
20-25
0.91
+135.1%
20-25
58.8%
+293.3%
20-25
30.8%
+185.7%
20-25
73.55
+451.5%
20-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €41k | €12k | €3k | €21k | €11k |
| Net profit | €23k | €6k | €-4k | €14k | €3k |
| Cash flow | €30k | €13k | €3k | €15k | €9k |
| Staff costs | - | - | - | - | - |
| Income taxes | €13k | €2k | €188 | €6k | €2k |
| Dividends | €24k | - | - | - | - |
| Total assets | €74k | €55k | €52k | €69k | €40k |
| Equity | €39k | €40k | €34k | €38k | €24k |
| Debt | €35k | €15k | €18k | €31k | €17k |
| of which ≤ 1y | €35k | €10k | €7k | €15k | €10k |
| of which > 1y | - | €5k | €11k | €16k | €7k |
| Working capital | €26k | €26k | €20k | €23k | €14k |
| Employees (FTE) | - | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.73 | 3.61 | 4.00 | 2.54 | 2.42 |
| Quick ratio | 1.73 | 3.61 | 4.00 | 2.54 | 2.42 |
| Working capital ratio | 34.5% | 47.7% | 39.3% | 33.3% | 33.4% |
| Solvency | 52.4% | 72.1% | 65.7% | 54.8% | 59.0% |
| Debt / equity | 0.91 | 0.39 | 0.52 | 0.83 | 0.69 |
| Long-term debt ratio | - | 0.13 | 0.32 | 0.43 | 0.30 |
| Interest coverage | 73.55 | 13.34 | 3.26 | 27.34 | 23.84 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 30.8% | 10.8% | -7.7% | 20.2% | 7.0% |
| ROE | 58.8% | 15.0% | -11.7% | 36.9% | 11.9% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €74k | €55k | €52k | €69k | €40k |
| Fixed assets | 21/28 | €13k | €19k | €25k | €31k | €17k |
| Tangible fixed assets | 22/27 | €13k | €19k | €25k | €31k | €17k |
| Current assets | 29/58 | €61k | €36k | €27k | €38k | €23k |
| Amounts receivable within one year | 40/41 | €48k | €31k | €20k | €23k | €12k |
| Cash & bank | 54/58 | €11k | €4k | €6k | €13k | €10k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €74k | €55k | €52k | €69k | €40k |
| Equity | 10/15 | €39k | €40k | €34k | €38k | €24k |
| Contributions / capital | 10/11 | €1 | €1 | €1 | €1 | €1 |
| Reserves | 13 | €37k | €38k | €38k | €38k | €24k |
| Accumulated profits (losses) | 14 | €2k | €2k | €-4k | - | - |
| Amounts payable | 17/49 | €35k | €15k | €18k | €31k | €17k |
| Amounts payable after one year | 17 | - | €5k | €11k | €16k | €7k |
| Amounts payable within one year | 42/48 | €35k | €10k | €7k | €15k | €10k |
| Trade debts payable within one year | 44 | €231 | €254 | €341 | €1k | €242 |
| Income statement | ||||||
| Gross operating margin | 9900 | €42k | €12k | €4k | €22k | €12k |
| Operating result | 9901 | €35k | €5k | €-4k | €20k | €5k |
| Financial income | 75 | €2k | €1k | €689 | €629 | €406 |
| Financial charges | 65 | €562 | €875 | €931 | €780 | €462 |
| Result before taxes | 9903 | €36k | €8k | €-4k | €20k | €5k |
| Income taxes | 67/77 | €13k | €2k | €188 | €6k | €2k |
| Net result for the period | 9904 | €23k | €6k | €-4k | €14k | €3k |
| Result to be appropriated | 9905 | €23k | €6k | €-4k | €14k | €3k |
Legal Structure
| NACE primary | Physiotherapy(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 13-02-2018 |
| Status | Active |
| Postal code | 7540 |
Establishment units
Marie VLS
since 20182.273.125.813
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 57042B0534/00N000 | Wallonia | 299 m² | 1 · 94 m² | 10.7 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €23k ▲283%
Operating result €35k, net result €23k, both a record.
06-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 6 days late
2024
31-12
Financial
Back to profitnet €6k
Net result €6k after one loss-making year.
07-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 7 days late
2023
31-12
Financial
Weakest financial yearnet €-4k ▼128%
Net result drops to €-4k, the lowest in the series; recovery starts the following year.
10-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 10 days late
2022
09-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 9 days late
2021
02-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 2 days late
2020
10-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 10 days late
2019
22-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Human health activities86905Physiotherapy86951
Names & trade names
| Legal nameFR | MARIE VLS |
Similar companies
DE LOGOHOEVE
BE 1011.593.895 · Stabroek
Physiomotion
BE 0742.961.404 · Mortsel
A.DAICHE KINE
BE 0793.982.909 · Herbeumont
CN3D
BE 0762.826.905 · Nivelles
Alderweireldt Kiné
BE 0766.332.365 · Waasmunster